IN2012DN03130A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03130A
IN2012DN03130A IN3130DEN2012A IN2012DN03130A IN 2012DN03130 A IN2012DN03130 A IN 2012DN03130A IN 3130DEN2012 A IN3130DEN2012 A IN 3130DEN2012A IN 2012DN03130 A IN2012DN03130 A IN 2012DN03130A
Authority
IN
India
Prior art keywords
propofol
compositions
aerosols
buccal
capsules
Prior art date
Application number
Other languages
English (en)
Inventor
Bastian Theisinger
Sonja Theisinger
Original Assignee
Novaliq Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaliq Gmbh filed Critical Novaliq Gmbh
Publication of IN2012DN03130A publication Critical patent/IN2012DN03130A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C19/00—Acyclic saturated compounds containing halogen atoms
    • C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3130DEN2012 2009-11-23 2010-11-22 IN2012DN03130A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09014548A EP2332525A1 (fr) 2009-11-23 2009-11-23 Composition pharmaceutique comprenant du propofol
PCT/EP2010/067938 WO2011061332A1 (fr) 2009-11-23 2010-11-22 Composition pharmaceutique comprenant du propofol

Publications (1)

Publication Number Publication Date
IN2012DN03130A true IN2012DN03130A (fr) 2015-09-18

Family

ID=41694756

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3130DEN2012 IN2012DN03130A (fr) 2009-11-23 2010-11-22

Country Status (12)

Country Link
US (1) US8796340B2 (fr)
EP (2) EP2332525A1 (fr)
JP (1) JP5707009B2 (fr)
KR (1) KR20120104262A (fr)
CN (1) CN102753159B (fr)
AU (1) AU2010320823B2 (fr)
BR (1) BR112012012108A2 (fr)
CA (1) CA2776855C (fr)
ES (1) ES2450423T3 (fr)
IN (1) IN2012DN03130A (fr)
MX (1) MX2012005881A (fr)
WO (1) WO2011061332A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2564502T3 (es) 2010-03-17 2016-03-23 Novaliq Gmbh Composición farmacéutica para el tratamiento de la presión intraocular aumentada
EP2444063A1 (fr) 2010-10-20 2012-04-25 Novaliq GmbH Compositions pharmaceutiques liquides pour l'administration de principes actifs
EP2462921A1 (fr) 2010-11-11 2012-06-13 Novaliq GmbH Compositions pharmaceutiques liquides pour le traitement d'une maladie de la chambre postérieure de l'oeil
CN103561724B (zh) 2011-05-25 2016-06-29 诺瓦利克有限责任公司 给药给甲的药物组合物
JP6039145B2 (ja) 2011-05-25 2016-12-07 ノバリック ゲーエムベーハー 半フッ化アルカンを基礎にした局所薬学的組成物
GB201116271D0 (en) 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
PT2806886T (pt) 2012-01-23 2017-03-24 Novaliq Gmbh Composições de proteínas estabilizadas baseadas em alcanos semifluorados
EP2895144B1 (fr) 2012-09-12 2017-01-11 Novaliq GmbH Compositions d'alcane semifluoré
MX363182B (es) 2012-09-12 2019-03-13 Novaliq Gmbh Composiciones que comprenden mezclas de alcanos semifluorados.
PL2708228T3 (pl) * 2012-09-12 2018-11-30 Novaliq Gmbh Kompozycje do przemywania oczu
DK3024484T3 (en) 2013-07-23 2018-10-08 Novaliq Gmbh STABILIZED ANTIBODY COMPOSITIONS
EP2944324A1 (fr) * 2014-05-13 2015-11-18 LTS LOHMANN Therapie-Systeme AG Utilisation d'alkanes semifluorés dans des systèmes d'administration transdermiques
EP3206683A4 (fr) 2014-10-16 2018-06-13 The Board of Trustees of the Leland Stanford Junior University Nouveaux procédés, composés et compositions d'anesthésie
EP3722274B1 (fr) 2015-09-30 2023-06-07 Novaliq GmbH 2-perfluorobutyl pentane pour administration ophtalmique
US20170087100A1 (en) 2015-09-30 2017-03-30 Novaliq Gmbh Semifluorinated compounds and their compositions
DK3442480T3 (da) 2016-06-23 2020-01-13 Novaliq Gmbh Fremgangsmåde til topisk indgivelse
KR102614858B1 (ko) 2016-09-22 2023-12-18 노바리크 게엠베하 안검염 치료에 사용되는 약제학적 조성물
AU2017329983B2 (en) 2016-09-23 2022-05-05 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
MX381639B (es) 2016-12-23 2025-03-13 Novaliq Gmbh Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
PL3612228T3 (pl) 2017-04-21 2024-04-08 Dermaliq Therapeutics, Inc. Kompozycje jodu
US11278503B2 (en) 2017-05-12 2022-03-22 Novaliq Gmbh Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
JP7814839B2 (ja) 2017-09-27 2026-02-17 ノバリック ゲーエムベーハー 眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
US11576893B2 (en) 2018-03-02 2023-02-14 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
AU2019246035B2 (en) 2018-03-28 2024-07-18 Novaliq Gmbh Pharmaceutical composition comprising timolol
JP7855312B2 (ja) 2018-04-27 2026-05-08 ノバリック ゲーエムベーハー 緑内障の治療のためのタフルプロストを含む眼科用組成物
WO2020064549A1 (fr) 2018-09-27 2020-04-02 Novaliq Gmbh Réparation de la barrière lipidique
CA3112031A1 (fr) 2018-10-12 2020-04-16 Novaliq Gmbh Composition ophtalmique pour le traitement d'une maladie oculaire seche
EP3923907B1 (fr) 2019-02-13 2024-09-25 Novaliq GmbH Compositions et procédés pour le traitement de la néovascularisation oculaire
CN114449999A (zh) 2019-09-06 2022-05-06 诺瓦利克有限责任公司 用于治疗葡萄膜炎的眼用组合物
EP3912622A1 (fr) 2020-05-19 2021-11-24 tesa Labtec GmbH Film oral d'administration sûre d'api

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496537A (en) * 1995-03-23 1996-03-05 Henry; Richard A. Propofol hydrofluorocarbon propellant formulations
DE19536504C2 (de) 1995-09-29 1999-09-23 H Meinert Verwendung fluorierter Alkane
WO2000054588A1 (fr) * 1999-03-15 2000-09-21 John Claude Krusz Traitement de maux de tete aigus et de douleur chronique au moyen de medicaments anesthesiques rapidement evacues dans des doses subanesthesiques
GB0124071D0 (en) * 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics
WO2005067517A2 (fr) * 2004-01-02 2005-07-28 Wisconsin Alumni Research Foundation Encapsulation de composes chimiques dans des micelles a noyau fluoritique et a enveloppe interne fluoree realises a partir de copolymeres sequences semi-fluores ou fluores
DE102004030044A1 (de) 2004-06-22 2006-01-12 Birken Gmbh Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
US9000048B2 (en) * 2006-11-28 2015-04-07 Wisconsin Alumni Research Foundation Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
PL2110126T3 (pl) * 2008-04-18 2012-04-30 Novaliq Gmbh Zastosowanie do inhalacji i zakraplania semifluorowanych alkanów jako nośników substancji aktywnych w strefie wewnątrzpłucnej

Also Published As

Publication number Publication date
AU2010320823B2 (en) 2014-06-26
EP2332525A1 (fr) 2011-06-15
EP2503999B1 (fr) 2013-12-25
US20120238639A1 (en) 2012-09-20
CA2776855C (fr) 2017-10-24
WO2011061332A1 (fr) 2011-05-26
AU2010320823A1 (en) 2012-07-12
BR112012012108A2 (pt) 2016-04-05
EP2503999A1 (fr) 2012-10-03
KR20120104262A (ko) 2012-09-20
ES2450423T3 (es) 2014-03-24
JP5707009B2 (ja) 2015-04-22
CN102753159B (zh) 2014-03-12
CA2776855A1 (fr) 2011-05-26
MX2012005881A (es) 2012-06-19
CN102753159A (zh) 2012-10-24
JP2013511496A (ja) 2013-04-04
US8796340B2 (en) 2014-08-05

Similar Documents

Publication Publication Date Title
MX2013001677A (es) Formulaciones estables de linaclotida.
BR112014009087A2 (pt) formulações de etanercept estabilizadas com xilitol
WO2011041729A3 (fr) Composés utiles comme antagonistes du récepteur de l'acide lysophosphatidique (lpa)
WO2011017350A3 (fr) Composés en tant qu'antagonistes du récepteur de l'acide lysophosphatidique
WO2011041461A3 (fr) Composés polycycliques utiles en tant qu'antagonistes du récepteur de l'acide lysophosphatidique
EA201290982A1 (ru) Фармацевтические композиции, препятствующие злоупотреблению
BR112012012081A2 (pt) método para o processamento de um arquivo de imagens médicas kobitidas em um procedimento de imagem guiada por protocolo ,equipamento para o processamento de um arquivo de imagens médicas obtidas por um procedimento de imagem guiada por protocolo e elemamto de programa de computador contendo conjuntos de instruções
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
MX2011011428A (es) Derivados de acido sulfamoilbenzoico como antagonistas de trpm8.
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
WO2011017502A3 (fr) Formulations comprenant du linaclotide
WO2010021607A3 (fr) Préparation pharmaceutique
WO2011157722A3 (fr) Composition contenant de l'ivabradine solide
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
MX340147B (es) Composiciones farmacéuticas y nutracéuticas del ácido abscísico.
WO2013134534A3 (fr) Formes à l'état solide de cabazitaxel et procédés pour les préparer
WO2011069037A3 (fr) Stabilisation et stockage de compositions pharmaceutiques biologiques
WO2010049449A3 (fr) Nouveaux sels de sunitinib
UA110979C2 (uk) Рідка фармацевтична композиція, яка включає нітизинон
WO2013114400A3 (fr) Compositions pharmaceutiques comprimées d'antipsychotiques atypiques
MX2010004899A (es) Conjugados de neurturina novedosos para uso farmaceutico.
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
WO2009140105A3 (fr) Préparations pour inhibiteurs de la cathepsine k
WO2013074871A3 (fr) Analogues d'humanine
IL206739A (en) An injectable drug containing silitol as an active substance